The association between SLAMF7 expression/signaling in B cells and susceptibility to CNS autoimmunity is supported by our adoptive transfer studies and is particularly exciting considering how the new B cell-depleting therapies are changing the landscape of contemporary MS treatment [8, 59]. The gene discussed is SLAMF7; the disease is myeloid sarcoma.